Aprea Therapeutics, Inc. (APRE)

Free Cash Flow

-$3.29M

Quarterly · Period ending: · USD

APRE logo

APRE Free Cash Flow

Latest reported-$3.29M
APRE Quarterly Free Cash Flow (-$3.15M → -$3.29M)
High-resolution chart · PNG

APRE free cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Free Cash Flow — Quarterly (USD)
Period endingFree Cash Flow (USD)
-3,294,163
-2,756,726
-2,961,292
-3,171,230
-3,130,754
-3,631,163
-3,510,904
-2,468,302
-3,649,121
-3,943,869
-3,746,808
-2,327,908
-3,216,904
-2,979,081
-4,020,512
-6,592,682
-8,902,613
-5,495,329
-10,178,787
-8,233,404
-7,751,883
-11,522,106
-13,215,492
-13,157,970
-9,636,292
-7,553,790
-10,443,780
-6,423,212
-5,606,286
-4,197,346
-3,850,465
-3,151,903
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.